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Detection of Functional Nicotinic Receptors Blocked by
a-Bungarotoxin on PC12 Cells and Dependence of Their
Expression on Post-Translational Events
Edward M. Blumenthal, William G. Conroy, Suzanne J. Romano, Paul D. Kassner, and Darwin K. Berg
Department of Biology, University of California, San Diego, La Jolla, California 92093
A major class of nicotinic receptors in the nervous system is
one that binds a-bungarotoxin and contains the a7 gene prod-
uct. PC12 cells, frequently used to study nicotinic receptors,
express the a7 gene and have binding sites for the toxin, but
previous attempts to elicit currents from the putative receptors
have failed. Using whole-cell patch-clamp recording tech-
niques and rapid application of agonist, we find a rapidly de-
sensitizing acetylcholine-induced current in the cells that can
be blocked by a-bungarotoxin. The current amplitude varies
dramatically among three populations of PC12 cells but corre-
lates well with the number of toxin-binding receptors. In con-
trast, the current shows no correlation with a7 transcript; cells
with high levels of a7 mRNA can be negative for toxin binding
and yet have other functional nicotinic receptors. Northern blot
analysis and reverse transcription-PCR reveal no defects in a7
RNA from the negative cells, and immunoblot analysis demon-
strates that they contain full-length a7 protein, although at
reduced levels. Affinity purification of toxin-binding receptors
from cells expressing them confirms that the receptors contain
a7 protein. Transfection experiments demonstrate that PC12
cells lacking native toxin-binding receptors are deficient at
producing receptors from a7 gene constructs, although the
same cells can produce receptors from other transfected gene
constructs. The results indicate that nicotinic receptors that
bind a-bungarotoxin and contain a7 subunits require additional
gene products to facilitate assembly and stabilization of the
receptors. PC12 cells offer a model system for identifying those
gene products.
Key words: nicotinic; acetylcholine receptors; a-bungaro-
toxin; PC12 cells; a7 gene product; a7 subunits; neuronal
One of the most abundant nicotinic acetylcholine receptors
(AChRs) in the vertebrate nervous system is a species that binds
a-bungarotoxin (aBgt) and contains a7 subunits (Sargent, 1993;
Role and Berg, 1996). The receptor is a cation-selective ligand-
gated ion channel with a high relative permeability to calcium and
rapid desensitization (Couturier et al., 1990; Schoepfer et al.,
1990; Zorumski et al., 1992; Alkondon and Albuquerque, 1993;
Bertrand et al., 1993; Seguela et al., 1993; Alkondon et al., 1994;
Zhang et al., 1994). It is capable of diverse functions, including
presynaptic modulation of transmitter release (McGehee et al.,
1995; Gray et al., 1996), postsynaptic generation of synaptic
currents (Zhang et al., 1996), and regulation of calcium-
dependent cellular events (Pugh and Berg, 1994; Vijayaraghavan
et al., 1995). Recent evidence also links it to a form of schizo-
phrenia (Freedman et al., 1997).
Heterologous expression of the a7 gene in Xenopus oocytes
and stably transfected cell lines produces functional aBgt-
sensitive receptors with pharmacological properties similar to
those of native receptors containing a7 subunits (Couturier et al.,
1990; Anand et al., 1993; Gopalakrishnan et al., 1995; Quik et al.,
1996). The a7 gene product may assemble into homomeric re-
ceptors, although a requirement for additional kinds of subunits
has not been excluded. Heteromers of a7 and a8 subunits have
been found among chick AChRs but represent a minority of the
receptors containing a7 protein (Schoepfer et al., 1990; Keyser et
al., 1993; Gotti et al., 1994). Interestingly, when Xenopus oocytes
are injected with the a7 gene alone, expression of functional
AChRs requires a cyclophilin acting either as a prolyl isomerase
or as a chaperone (Helekar et al., 1994). It is not known whether
neurons have a similar requirement for cyclophilin.
A continuing challenge to our understanding of receptors con-
taining a7 subunits is that presented by the rat pheochromocy-
toma cell line PC12 (Greene and Tischler, 1976). PC12 cells
express the a7 gene product, along with other nicotinic receptor
genes (Boulter et al., 1986, 1990; Rogers et al., 1992; Henderson
et al., 1994). Although the cells can assemble receptors that bind
aBgt, no electrophysiological response or ion flux has been attrib-
uted to the receptors despite attempts for nearly two decades
(Patrick and Stallcup, 1977a,b; Amy and Bennett, 1983; Kemp
and Edge, 1987; Daly et al., 1991; Rogers et al., 1991). In contrast,
autonomic neurons, which express a similar complement of
AChR genes (Listerud et al., 1991; Corriveau and Berg, 1993;
Mandelzys et al., 1994), assemble substantial numbers of func-
tional aBgt-sensitive AChRs that contain a7 subunits and lack
the other known AChR gene products present (Vernallis et al.,
1993; Zhang et al., 1994). The one indication of functional
aBgt-sensitive AChRs on PC12 cells comes from studies showing
that aBgt blocks the effects of nicotine on neurite outgrowth from
the cells (Chan and Quik, 1993). We reexamine here the question
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of whether PC12 cells express AChRs that contain a7 subunits
and generate aBgt-sensitive currents.
MATERIALS AND METHODS
PC12 cells. PC12 cells were obtained from M. Quik (McGill University)
(PC12-A), S. Rogers (University of Utah) (PC12-B), and R. T. Boyd
(Ohio State University) (PC12-C). The cell lines were grown at 37°C in
a humidified incubator under 8% CO2 and passaged when 70–80%
confluent (trypsin was used to passage the PC12-A cells). The cultures
were replaced after 2–3 months of passage by thawing a fresh aliquot of
frozen cells. Each strain was maintained in culture medium of the
composition used by the source laboratory: PC12-A received DMEM
with 4.5 gm/l glucose, 5% heat-inactivated fetal bovine serum (Gemini
Bio-Products, Calabasas, CA), and 10% heat-inactivated donor horse
serum (Gemini); PC12-B received DMEM with 1 g/ l glucose, 10%
heat-inactivated fetal bovine serum (Characterized; HyClone, Logan,
UT), and 5% heat-inactivated donor horse serum (Gemini); PC12-C
received RPMI 1640 medium with 5% heat-inactivated fetal bovine
serum (Gemini) and 10% heat-inactivated donor horse serum (Gemini).
All media contained 2 mM glutamine and 50 U/ml penicillin and strep-
tomycin. In some experiments the culture medium was supplemented
with 50–100 ng/ml nerve growth factor (7 S NGF; Promega, Madison,
WI) for 3–5 d before assaying the cells.
Electrophysiology. For electrophysiological experiments, cells were
plated at low density on 35 mm tissue culture dishes and used the
following day. For PC12-A cells the dishes were first coated with poly-
L-lysine (Sigma, St. Louis, MO). Currents were recorded using the
whole-cell patch-clamp configuration controlled by an Axopatch 200A
amplifier (Axon Instruments) as described previously (Hamill et al.,
1981; Zhang and Berg, 1995). The extracellular solution contained (in
mM) 140 NaCl, 3 KCl, 2 MgCl2 , 2 CaCl2 , 10 glucose, and 10 HEPES, pH
7.4 (with NaOH). The pipette solution contained (in mM) 140 CsCl, 1
MgCl2 , 10 EGTA, 10 glucose, and 10 HEPES, pH 7.2 (with CsOH).
Electrode resistances were ;3 MV. Series resistance was always ,6 MV
and was 80% compensated. Cells were clamped at 260 mV, and 500 mM
ACh was rapidly applied as follows. Solutions were delivered from a
linear array of glass tubing (370 mm inner diameter, 470 mm outer
diameter; Polymicro Technologies, Phoenix, AZ) mounted on a piezo
bimorph element (Morgan-Matroc, Bedford, OH). Solution flow was
gravity-fed and controlled by a set of solenoid valves (General Valve,
Fairfield, NJ). The valves and the bimorph were all controlled by a
Master-8 programmable stimulator (A.M.P.I., Jerusalem, Israel). Using
this system, the time of solution exchange at an open pipette was 0.5–3
msec as measured by the change in junction potential. Data were filtered
at 1 kHz and digitized at either 0.7 or 2 kHz with the pClamp software
(Axon Instruments). Currents were analyzed using Axograph (Axon
Instruments). Maximum activation rates were calculated using the Axo-
graph subroutine and normalized to peak amplitude.
For recordings from aBgt-treated cells, the toxin (Biotoxins Inc., St.
Cloud, FL) was applied at 60 nM for 1–3 hr at 37°C, and 18 nM aBgt was
also included in the recording solution. For some experiments 1 mg/ml
BSA (Sigma; fraction V, cold alcohol precipitation) was included in the
recording solution, because it increased the amplitude of the nicotinic
responses that could be elicited from cells after multiple passages in
culture. Exposure to BSA had no effect on the aBgt sensitivity of the
response; therefore, results obtained in the presence and absence of BSA
were combined in the present analysis. The mechanism of the BSA effect
is unknown, although it may be similar to the increased nicotinic re-
sponse seen in chick ciliary ganglion neurons after acute exposure to
BSA (Gurantz et al., 1993).
Monoclonal antibodies. Monoclonal antibodies (mAbs) 318 and 319 were
raised against a fusion protein corresponding to the large putative cyto-
plasmic loop of the chick a7 gene product (Schoepfer et al., 1990); mAb 319
cross-reacts with the rat a7 protein in detergent extracts and on immuno-
blots, whereas mAb 318 does not (Del Toro et al., 1994) (W. Conroy and D.
Berg, unpublished observations). mAb A7–1 has not been described pre-
viously. It was raised against a fusion protein corresponding to the large
putative cytoplasmic loop of the rat a7 gene product including amino acids
301–439 (numbering as in Seguela et al., 1993). The fusion protein was
prepared by generating a PCR fragment encoding the desired region,
cloning it into the pRSETB expression vector (Invitrogen, San Diego, CA),
and expressing it in bacteria [BL21(DE3)pLysE]. The fusion protein was
purified by metal affinity chromatography and used as an immunogen for
mAb production as described previously (Vernallis et al., 1993). Hybrido-
mas were screened for antibodies that could immunoprecipitate aBgt
binding sites labeled with 125I-aBgt in PC12 cell extracts. mAb A7–1 was
found to be an IgG1 and was used as diluted ascites fluid for probing
immunoblots. mAb 289 recognizes an epitope between residues 330 and
511 on the a4 gene product (Whiting et al., 1991a). The anti-myc mAb 9E10
was obtained commercially (Santa Cruz Biotechnology, Santa Cruz, CA).
Binding assays. The number of aBgt binding sites on the surface of
PC12 cells was determined as described (Halvorsen and Berg, 1989).
PC12 cells were plated on 24 well plates at 10 5 cells/16 mm well 24–48
hr before the assay was conducted. Culture medium was removed and
immediately replaced with identical medium that included 10 nM 125I-
aBgt with and without either 1 mM aBgt or 250 mM nicotine. The cells
were incubated for 1 hr at 37°C and then were rinsed four times with 2
ml aliquots of HEPES solution (137 mM NaCl, 5.4 mM KCl, 0.8 mM
MgSO4 , 0.9 mM NaPO4 , 0.4 mM K2PO4 , 1.8 mM CaCl2 , 2 mg/ml BSA,
and 10 mM HEPES, pH 7.4). Cells were solubilized and scraped in 0.5 ml
of 1N NaOH; bound radioactivity was quantified by gamma counting.
Nonspecific binding determined in the presence of excess unlabeled aBgt
or nicotine was subtracted to yield specific binding. Results were nor-
malized to total protein, which was assayed by scraping cells in 2% SDS
and 0.1N NaOH and conducting the BCA protein assay (Pierce, Rock-
ford, IL) with BSA as a standard. Determinations were done in triplicate
within each experiment.
Both aBgt and epibatidine binding were determined in cell extracts by
scraping PC12 cells into PBS containing 5 mM EDTA and 5 mM EGTA,
collecting the cells by centrifugation, and freezing at 280°C until needed.
Frozen cells were thawed and solubilized in 50 mM sodium phosphate,
pH 7.4, containing 1% (v/v) Triton X-100 and the following protease
inhibitors: iodoacetamide (0.4 mM), benzamidine (5 mM), phosphoram-
idon (5 mg/ml), soybean trypsin inhibitor (10 mg/ml), leupeptin (10
mg/ml), pepstatin A (20 mg/ml), EDTA (5 mM), EGTA (5 mM), aprotinin
(2 mg/ml), and phenylmethylsulfonyl fluoride (1 mM). Insoluble material
was removed by centrifugation for 15 min in a microfuge at 4°C. Deter-
gent extracts were assayed in either of two ways. In one, aliquots (25–50
ml) of the three PC12 lines were incubated with 10 nM 125I-aBgt or 1–5
nM 3H-epibatidine (DuPont NEN, Boston, MA) for 1 hr at room tem-
perature. The reaction was stopped by the addition of 4 ml of 10 mM Tris
buffer, pH 7.5, containing 0.05% Triton X-100 (Tris-TX) and immediate
filtration through Whatman (Maidstone, UK) GF/B filters treated with
0.5% polyethyleneimine. The filters were washed twice with Tris-TX and
counted in a gamma counter to quantify 125I-aBgt or in a scintillation
counter to measure 3H-epibatidine.
In the second method, detergent extracts were assayed in two-site
solid-phase radioimmunoassays (RIAs) as described previously (Conroy
and Berg, 1995). Briefly, subunit-specific mAbs were used to immu-
notether receptors from detergent extracts in microtiter wells, and bound
receptors were quantified with radiolabeled probes and either gamma or
scintillation counting. AChRs containing a7 protein were retained with
the anti-a7 mAb 318 or 319 and quantified with 125I-aBgt; AChRs
containing the a4 and b2 gene products were retained with the anti-a4
mAb 289 and quantified with 3H-epibatidine; chimeric receptors contain-
ing the a7/5-HT3 receptor construct (see below) were retained with the
anti-myc mAb 9E10 (via an incorporated myc epitope) and quantified
with 125I-aBgt. Nonspecific binding in both methods was determined in
the presence of 1 mM aBgt (aBgt assay), 1 mM epibatidine (epibatidine
assay), or 250 mM nicotine (both assays). Results were normalized to total
protein as described above. Triplicate determinations were done for each
sample.
Receptor purification and immunoblot analysis. PC12-B and -C cells were
harvested from 20 100 mm culture plates and solubilized with buffer
containing 1% Triton X-100 as described above. Samples were incubated
with 20–50 ml aBgt coupled to Actigel (Sterogene) for 20 hr at 4°C. For
negative controls, 250 mM nicotine was included in the incubation with the
aBgt. After several washes with PBS containing 0.5% Triton X-100, bound
material was eluted with SDS-PAGE sample buffer, and the samples were
subjected to SDS-PAGE, electroblotted onto nitrocellulose, and probed
with anti-a7 mAbs 319 or A7–1 as described (Corriveau et al., 1995).
Bound mAb was detected with a horseradish peroxidase-coupled anti-
mouse secondary antibody and visualized using enhanced chemilumines-
cence (Amersham, Arlington Heights, IL) and autoradiography.
Total a7 protein was immunoprecipitated from solubilized cell extracts
(1 ml prepared from 30 100 mm plates) of either PC12-B or -C cells using
mAb 319 coupled to Actigel (20 ml), incubating, and rinsing as above.
The bound material was eluted and analyzed on immunoblots probed
with mAb A7–1 as described above.
RNA isolation. Total RNA was isolated from PC12 cell cultures by acid
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guanidinium thiocyanate–phenol–chloroform extraction (Chomczynski
and Sacchi, 1987). RNA was quantified by measuring optical density at
260 nm; RNA integrity was routinely checked by formaldehyde agarose
gel electrophoresis.
RNase protection. 32P-labeled riboprobes used for RNase protection
experiments were generated by “runoff transcription” from appropriately
linearized constructs using methods described previously (Corriveau and
Berg, 1993). The a3 probe construct was made by subcloning a fragment
encoding amino acids 346–441 from a full-length rat a3 cDNA (Boulter
et al., 1986) into pGEM-T (Promega). For the b2 probe construct, a 370
base pair fragment was subcloned into pGEM-T from a full-length rat b2
cDNA to generate a probe encompassing amino acids 334–457 (Deneris
et al., 1988). Portions of the rat a5, a7, and b4 cDNAs were isolated by
reverse transcription (RT)-PCR from PC12 total RNA, and the frag-
ments were directly cloned into PGEM-T. The b4 probe encodes amino
acids 343–442, the a5 probe encodes amino acids 339–405 (Boulter et al.,
1990), and the a7 probe encodes amino acids 305–438 (Seguela et al.,
1993). The undigested and protected probe sizes, respectively, in base
pairs are as follows: a3, 320 and 283; a5, 315 and 203; a7, 507 and 402;
b2, 470 and 370; and b4, 372 and 301.
RNase protections were performed essentially as described previously
(Corriveau and Berg, 1993). For quantification, signals were measured
directly from the gels using a Bio-Rad (Richmond, CA) Molecular
Imager. Direct comparisons between the subunits were made by taking
into account probe-specific activity and the total amount of RNA ana-
lyzed. The linearity of the assay was confirmed by varying the amount of
total mRNA and quantifying the resulting a7 signal.
Northern blots. PC12 RNA samples were fractionated on 1% agarose
gels containing 7.4% formaldehyde and transferred to a Hybond N nylon
membrane (Amersham) by capillary blot according to the instructions of
the manufacturer. A gel-purified fragment of the a7 cDNA encoding
amino acids 305–438 was labeled to about 10 9 cpm/mg with [a-32P]dCTP
using a random-primed labeling kit (Gibco-BRL, Bethesda, MD). Mem-
branes were prehybridized and hybridized in Rapid-Hyb solution (Am-
ersham) as recommended by the supplier. Nonspecific radioactivity was
removed by two 20 min washes at 65°C in 0.13 SSC containing 0.1%
SDS. Filters were exposed to Kodak XAR-5 film at 270°C with a
DuPont Cronex intensifying screen for 1–2 d.
RT-PCR analysis. First-strand cDNA was synthesized from PC12-B
and -C total RNA using a Superscript reverse transcriptase kit (Gibco-
BRL). PCR was performed using the PCR Optimizer kit (Invitrogen)
and the following primers: for fragment a, 59-aggcatctggctggctctg-39 and
59-tgattctggtccacttaggc-39; for fragment b, 59-ctatgagtgctgcaaagagc-39 and
59-tgattctggtccacttaggc-39; for fragment c, 59-ctatgagtgctgcaaagagc-39 and
59-tctgcgcatttcctacttg-39; and for fragment d, 59-acctgctctacattggcttc-39
and 59-tctgcgcatttcctacttg-39. The PCR fragments were separated on
1.1% agarose gels and visualized by staining with ethidium bromide. Gels
were photographed using a Polaroid instant camera.
Chimeric construct. An a7/5-HT3 chimeric receptor gene construct
similar to that described previously (Elsele et al., 1993) was made that
encoded the N-terminal portion of the chicken AChR a7 subunit extend-
ing up to the first putative transmembrane domain (through Thr 230) and
then continued with the remainder of rat 5-HT3 receptor subunit (start-
ing with Pro 258; designating the methionine initiation codon as number
1). A sequential overlapping PCR method was used to join the two
cDNAs in frame without the need for matching restriction endonuclease
sites (Herlitze and Koenen, 1990). The a7 cDNA was used as a template
with oligo-A7NdeIdn (atcttggacatatggaggctgg) and 1u (aataaaggagttct-
gcgtctcatg). The 5-HT3 receptor cDNA was used as a template with
oligo-1d (gcagaactcctttattctacgcag) and oligo-5HT3RXhoI (accctcgagg-
gaataatgccaaatg). The resulting overlapping products were gel-purified
and used together as a template with the A7NdeIdn and 5HT3RXhoI
oligos. The product was subcloned into the pGEM-T vector (Promega),
and double-stranded dideoxy sequencing (Sequenase; United States Bio-
chemicals, Cleveland, OH) was performed to confirm the sequence. The
SacI–EcoRI fragment of pOPCMVSLa7myc (constituting a portion of
the pOPCMVSL vector and 59 coding region of a7) and EcoRI-PflMI
and PflMI-XhoI fragments of the PCR product were cloned into the
SacI–XhoI fragment of pOPCMVSLa7myc (the remaining portion of
the pOPCMVSL vector).
Transfections. Transient transfection of PC12 cells was accomplished
using LipofectAMINE (Gibco-BRL) according to the instructions of the
manufacturer and was usually performed in either 60 or 100 mm culture
dishes, and the cells were taken for analysis after 20–48 hr. The trans-
fections used the chimeric a7/5-HT3 receptor gene construct (see above),
chicken a7 constructs, or chicken a4 and b2 constructs. The chicken b2
and a4 constructs were kindly provided by Dr. Paul Whiting (Merck,
Sharp, & Dohme Laboratories, Essex, UK) as expression constructs
pCDM8-Ch 23.1 and pCDM8-Ch 26.1 containing the b2 and a4 cDNAs,
respectively, under cytomegalovirus (CMV) promoters (Whiting et al.,
1991b). The chicken a7 constructs were prepared from chicken a7 cDNA
under CMV promoters in pOPCMVSL with and without myc epitopes
at the C terminus (additional details to be described elsewhere; P.
Kassner and D. Berg, unpublished data).
Materials. aBgt was purchased from Biotoxins and radioiodinated to a
specific activity of 0.5–0.7 3 10 18 cpm/mol using chloramine T. 3H-
Epibatidine (56.5 Ci /mmol) was a gift from DuPont NEN; unlabeled
epibatidine was purchased from Research Biochemicals International.
mAbs 289, 318, and 319 were supplied by Dr. Jon Lindstrom (University
of Pennsylvania, Philadelphia, PA). mAb 319- and aBgt-Actigel were
prepared at 2 and 4–6 mg/ml, respectively, according to the instructions
of the manufacturer (Sterogene). The rat a5, a7, and b4 probes and the
a7 cytoplasmic fragment were RT-PCR-cloned by Dr. John Willoughby
(University of British Columbia, Vancouver, Canada). Dr. Jim Boulter
(University of California, Los Angeles, CA) provided the rat a3 and b2
cDNAs. All compounds were purchased from Sigma unless otherwise
indicated.
RESULTS
Discovery of aBgt-sensitive ACh responses
Whole-cell patch-clamp recording was used to examine ACh-
induced currents in three populations of PC12 cells obtained
from three different laboratories. Agonist was applied by a rapid
delivery system to optimize detection of quickly desensitizing
currents. ACh at 500 mM elicited two kinds of responses that
could be distinguished by their apparent kinetics of activation,
their rates of desensitization, and their sensitivity to aBgt. One
was a rapidly activating current that quickly desensitized and
could be blocked by aBgt. The other was a more slowly activating
current that decayed less quickly and was insensitive to the toxin.
The relative proportions of the two kinds of responses differed
dramatically among the three PC12 populations tested (Fig. 1,
Table 1). PC12-A cells displayed only the rapidly desensitizing
response that was completely blocked by 60 nM aBgt (Fig. 1A).
PC12-B cells, in contrast, had only the slowly desensitizing re-
sponse that was insensitive to blockade by aBgt (Fig. 1B). PC12-C
cells had both kinds of responses (Fig. 1C).
In the case of mixed responses, one method of detecting the
rapidly desensitizing toxin-sensitive component is to compare the
proportion of the current remaining 30 msec after the peak in the
presence and absence of aBgt. By this criterion PC12-C cells have
a toxin-sensitive component, whereas PC12-B cells do not (Table
1). A more sensitive method for revealing even a small amount of
the toxin-sensitive response in the presence of a large insensitive
response is to take advantage of the observed rapid activation
kinetics of the toxin-sensitive component. This was done by calcu-
lating the maximum rate of current activation for each cell and
normalizing it to the peak amplitude of the response. Comparing
these values in the presence and absence of aBgt again reveals the
rapidly activating aBgt-sensitive current in PC12-C cells but fails to
detect such a component in PC12-B cells (Table 1).
Correlation between aBgt-sensitive responses and
aBgt binding sites
The differential effect of aBgt on the two classes of ACh-evoked
currents suggested that they arose not from different gating
modes of a single class of receptor but rather from two pharma-
cologically distinct receptor subtypes. Accordingly, binding stud-
ies were performed to distinguish AChR classes pharmacologi-
cally and to correlate them with the currents observed. 125I-aBgt
was used to quantify aBgt binding sites both on the cell surface
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and in cell extracts. 3H-Epibatidine was used to quantify other
classes of nicotinic receptors in the extracts. Epibatidine binds
with high affinity to many nicotinic receptor subtypes but not
those containing rat or chick a7 subunits (Gerzanich et al., 1995)
(W. Conroy and D. Berg, unpublished observations). Binding to
the cell surface was not attempted with 3H-epibatidine, because it
seems to cross the cell membrane.
PC12-A cells had a small but significant number of aBgt bind-
ing sites on the cell surface, whereas PC12-C cells had substan-
tially more (Fig. 2). Both had even greater numbers in cell
extracts, implying the existence of intracellular pools of the
receptors. PC12-B cells, in contrast, had no detectable sites on the
surface and few, if any, in the cell extracts. This pattern of
expression could not be explained by the different culture media
used for the three populations. Growing the PC12-B cells in
culture medium normally used for PC12-C cells did not result in
the expression of aBgt binding sites. Conversely, PC12-C cells
grown in PC12-B medium continued to express aBgt binding sites
(data not shown).
NGF increases the excitability of PC12 cells (Dichter et al., 1977;
Mandel et al., 1988) and can induce long-term expression of a
sodium channel gene after even a brief exposure (Toledo-Aral et
al., 1995). Because NGF also increases AChR expression in at least
some populations of PC12 cells (Dichter et al., 1977; Henderson et
al., 1994), its effects on PC12-B cells were tested to determine
whether it could induce the appearance of aBgt-sensitive AChRs.
Exposure of the cells to 100 ng/ml NGF for 4 d failed to induce any
morphological changes or to arrest cell growth and division. Con-
sistent with their nonresponsive phenotype, PC12-B cells in the
presence of NGF did not express detectable levels of aBgt binding
(two experiments gave values of 0.0 6 2.0 and 0.2 6 1.0 fmol of
aBgt binding/mg of protein). NGF treatment stopped cell division
in PC12-C cells and caused them to extend neurites, as previously
reported for the parent line (Greene and Tischler, 1976), but it had
no effect on the expression of aBgt binding sites by the cells (two
experiments gave 277 6 29 and 371 6 12 fmol/mg protein com-
pared with the mean of about 280 fmol/mg protein for untreated
control cells as shown in Fig. 2).
The distribution of aBgt binding sites among the three cell
populations correlates with the presence of aBgt-sensitive cur-
rents evoked by ACh in the cells. The other class of receptors,
namely those binding epibatidine, is likely to be responsible for
the aBgt-insensitive currents evoked by ACh. Extracts from all
three strains had significant numbers of such receptors, but only
the PC12-B and PC12-C cells displayed the slow, toxin-insensitive
response (see Discussion).
Lack of correlation between aBgt-sensitive responses
and a7 mRNA
Because AChRs that bind aBgt in autonomic neurons have been
shown to contain the a7 gene product (Schoepfer et al., 1990;
Vernallis et al., 1993), experiments were performed to compare
the levels of a7 transcript among the three PC12 populations.
RNase protection assays revealed the presence of a7 mRNA in all
three types of PC12 cells (Fig. 3A). In fact, PC12-B cells, which
lack detectable aBgt binding sites, had by far the greatest abun-
dance of a7 transcripts (Fig. 3B). PC12-B cells also expressed
substantial amounts of the other four AChR gene transcripts
tested: a3, a5, b2, and b4. PC12-A and -C cells expressed the
same five genes, with the exception of b4 in PC12-A. The lack of
b4 transcripts in PC12-A cells might account for the absence of a
Figure 1. aBgt blockade of ACh-evoked currents in PC12 cells. Whole-
cell patch clamp was used to measure currents evoked in PC12-A (A),
PC12-B (B), and PC12-C (C) cells by rapid application of 500 mM ACh in
the presence and absence of aBgt. Each panel shows typical responses
from a control cell (light trace) and a cell incubated with 60 nM aBgt for
1–3 hr (heavy trace) superimposed. PC12-A cells display a small, rapidly
activating current that quickly desensitizes and is completely blocked by
aBgt; PC12-B cells show a large, slowly activating current that is com-
pletely insensitive to aBgt; PC12-C cells have both kinds of responses.
Holding potential, 260 mV. Calibration bars: horizontal, 100 msec;
vertical, 300 pA. The initiation and duration of ACh application are
indicated by the vertical deflection and heavy horizontal arrow, respectively.
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slow aBgt-insensitive response, which was prominent in PC12-B
and -C cells.
One explanation for the finding that PC12-B cells express a7
mRNA and yet fail to assemble aBgt-binding AChRs is that the
transcripts may be defective. A first test of this was performed by
Northern blot analysis. Total RNA was extracted from both
PC12-B and PC12-C cells and probed on Northern blots with a
random-primed, 32P-labeled a7 probe. A single band of about 6.4
kb was observed in the two samples (Fig. 4). The results indicate
that the defect preventing accumulation of aBgt-sensitive AChRs
in PC12-B cells is unlikely to result from a large truncation or
deletion in the a7 transcript.
Bovine adrenal chromaffin cells express a truncated splice
variant of the a7 transcript that lacks 87 nucleotides correspond-
ing to an exon encoding the M2 domain and adjacent regions
(Garcia-Guzman et al., 1995). When co-injected with full-length
a7 transcript into Xenopus oocytes, the truncated splice variant
inhibits the expression of functional AChRs. A deletion of this
size would probably not have been detected in the Northern
analysis. Therefore, RT-PCR analysis was performed over the
region in question as well as adjacent regions to determine
whether such a deletion might account for the inability of PC12-B
cells to produce competent aBgt-binding AChRs. Primers were
chosen to amplify fragments corresponding to nucleotide posi-
tions 18–1000 (a), 627–1000 (b), 627–1534 (c), and 1148–1534 (d)
(Fig. 5A; numbering as in Seguela et al., 1993). Only the expected
full-length fragment was obtained in each case, and no size
differences were detected between PC12-B and -C cells (Fig. 5B).
The small 627–1000 fragment includes the M2 region; even a
deletion of 10–20 nucleotides should have been apparent. The
RNase protections (covering positions 913–1314), the PCR anal-
ysis, and the Northern blots found no defects in the a7 mRNA
from PC12-B cells.
Presence of a7 protein in PC12 AChRs
In view of the transcript analysis, it became important to confirm
that PC12 receptors capable of binding aBgt actually contain a7
subunits. This was demonstrated by using aBgt-Actigel to affinity
purify the receptors from PC12 cell extracts and then analyzing
the eluted protein on immunoblots. The blots were probed with
the anti-a7 mAb A7–1 generated against a fusion protein corre-
sponding to the large putative cytoplasmic loop of the rat a7 gene
product. A single component of ;60 kDa was recognized by the
mAb in extracts from PC12-C cells (Fig. 6A). It was comparable
in size to the monomeric a7 species obtained from chick brain
and ciliary ganglion (Schoepfer et al., 1990; Vernallis et al., 1993).
Competition with 250 mM nicotine during the affinity purification
caused the complete loss of the PC12 component, confirming the
specificity of the purification. No specific bands were detected in
extracts prepared from PC12-B cells. The results demonstrate
that the aBgt-binding species in PC12 cells contains the a7 gene
product.
Immunoblot analysis of immunopurified material was used to
compare the total amounts of a7 protein in extracts prepared
from PC12-B and -C cells. mAb 319 coupled to Actigel was used
to immunoprecipitate a7 protein, whereas mAb A7–1 was used to
detect it on the blots. Although a7 protein could be detected in
both cases, PC12-C cells contained much more of it than did
Figure 2. Differences among PC12 populations in their rela-
tive levels of AChRs that bind aBgt and epibatidine. 125I-aBgt
was used to measure binding sites on intact cells, whereas both
125I-aBgt and 3H-epibatidine were used to quantify sites in cell
extracts. The results were normalized for total protein. Non-
specific binding was determined by adding 1 mM aBgt (aBgt
assays), 1 mM epibatidine (epibatidine assay), or 250 mM nico-
tine (both assays) to the binding reactions and was subtracted
from the values shown. PC12-A and -C cells express significant
amounts of aBgt binding sites both on the surface (solid bars)
and in cell extracts (stippled bars), whereas PC12-B cells have
few if any specific aBgt binding sites. All three populations
have significant epibatidine binding (hatched bars). Data rep-
resent the mean 6 SEM of triplicate determinations from four
to seven independent experiments.
Table 1. Effects of aBgt on the properties of ACh-evoked currents in PC12 cells
Cell type n
Cm
(pF)
Current
(pA)
Current density
(pA/pF) I30/Ipeak
Activation rate
(sec21)
PC12-A 148 10.9 6 0.3 215 6 30 19 6 2 0.11 6 0.01 256 6 15
1 aBgt 40 11.4 6 0.6 0 0 — —
PC12-B 73 11.7 6 0.3 1814 6 179 154 6 14 0.92 6 0.01 60 6 2
1 aBgt 3 11.5 6 0.4 2121 6 247 192 6 23 0.92 6 0.01 57 6 2
PC12-C 117 14.6 6 0.3 2418 6 181 178 6 14 0.74 6 0.02 120 6 5
1 aBgt 5 14.6 6 0.4 1763 6 146* 131 6 12* 0.90 6 0.01** 69 6 2**
Whole-cell patch clamp was used to record responses evoked by 500 mM ACh in the presence and absence of 60 nM aBgt. The peak current in each case was divided by the
capacitance (Cm) to obtain the current density for individual cells. I30/Ipeak is the current amplitude 30 msec after the peak current divided by the latter. The activation rate
was calculated as the maximum of the derivative of the current normalized to the peak current. Currents ,100 pA were not included in the calculations of activation rate.
Values represent the mean 6 SEM. The number of cells is indicated by n.
*, **Significantly different from paired values in the absence of aBgt; *p # 0.02; **p # 0.001, Student’s t test.
6098 J. Neurosci., August 15, 1997, 17(16):6094–6104 Blumenthal et al. • Nicotinic Receptors on PC12 Cells
PC12-B cells (Fig. 6B). The size of the monomeric a7 protein in
PC12-B and -C cells is the same, consistent with the PCR and
Northern analyses finding no differences in transcript size.
Expression of AChRs from transfected genes
The small amounts of a7 protein in PC12-B cells suggested that
the transcript was competent but that a posttranslational block
prevented assembly of the subunits and permitted rapid turnover.
The possibility of a posttranslational block was tested by trans-
fecting cells with chicken AChR gene constructs and then assay-
ing cell extracts for receptor expression. Because the anti-a7 mAb
318 is specific for chicken, it enabled the transfected a7 gene
product to be distinguished from the endogenous rat homolog in
solid-phase RIAs. The relative amounts of aBgt binding in such
assays in which only the chick a7 gene product was measured
indicated that PC12-B cells are two orders of magnitude less
efficient than PC12-C cells at producing AChRs from a compe-
tent a7 cDNA construct (Fig. 7A).
For comparison, cells were also transfected with the chicken a4
and b2 genes and assayed by RIA using the anti-a4 mAb 289 to
immunotether receptors and 3H-epibatidine to quantify them. In
contrast to the results with the a7 construct, PC12-B cells were
only a few-fold less efficient than PC12-C cells at producing
transfected a4/b2 AChRs (Fig. 7A). A comparison was also
performed using an a7/5-HT3 chimeric receptor gene construct in
which the 59-terminal portion of the 5-HT3 receptor gene encod-
ing the N-terminal putative extracellular portion of the protein
was replaced with the equivalent region of the a7 gene. The
encoded protein retains the ability to bind aBgt (Elsele et al.,
1993). The construct was also engineered to encode a myc epitope
on the C terminus so that the anti-myc mAb 9E10 could be used
to immunotether the chimeric receptor in RIAs. Again, PC12-B
cells were only a few-fold less efficient than PC12-C cells at
expressing the transfected chimeric receptors (Fig. 7A).
A different way of analyzing the data is to calculate the ratio of
different receptor types produced by transfected PC12-B cells and
then to compare the ratio with that obtained from transfected
PC12-C cells. This provides a way of normalizing results among
experiments and reduces the inherent variation among transfec-
tions. Viewing the results in this way indicates that PC12-B cells
are 10- to 20-fold less able to produce receptors from the trans-
fected a7 construct than they are from either the transfected a4
and b2 constructs or from the transfected a7/5-HT3 chimeric
receptor construct compared with PC12-C cells (Fig. 7B). If all of
the differences between PC12-B and -C cells in expressing either
a4/b2 receptors or a7/5-HT3 receptors were considered nonspe-
cific, e.g., attributed to differences in the efficiency of transfection,
Figure 3. Relative amounts of AChR gene transcripts in three PC12
populations. RNase protection assays were used to measure the levels of
a3, a5, a7, b2, and b4 transcripts in PC12-A–PC12-C cells. A, Represen-
tative RNase protection autoradiogram in which 20 mg samples of total
RNA were hybridized with a 32P-labeled a7 riboprobe (Probe lane, ar-
rowhead). tRNA (15 mg) served as a negative control; neither it nor probe
alone protected a radiolabeled species (tRNA lane). Each PC12 RNA
sample protected an a7 band of the expected size (arrow); the levels of a7
mRNA varied among the three cell populations, with the PC12-B cells
expressing the most. B, The protected species obtained with each of the
five probes was quantified on a Bio-Rad Molecular Imager. The results
represent the mean 6 SEM for three to seven determinations from a total
of three or four RNA preparations and are normalized to the signal
obtained for a3 transcript in PC12-A cells.
Figure 4. Northern blot analysis demonstrating a7 transcripts of equiv-
alent size in PC12-B and PC12-C cells. Total RNA was isolated from each
population and subjected to electrophoresis on a formaldehyde–agarose
gel followed by capillary blotting onto a nylon membrane. The blot was
hybridized with random-primed, 32P-labeled probe directed to the cyto-
plasmic domain of a7. Bars indicate the 28 and 18 S ribosomal RNAs.
Both populations express a single a7 transcript ;6.4 kb in length (arrow-
head). The results are qualitative with respect to band intensity and
should not be used to assess relative abundance of the transcripts. Similar
results were obtained in four other experiments.
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the results would still demonstrate a substantial difference be-
tween the two cell populations in their ability to produce AChRs
with a7 subunits. It is at least as likely, however, that all of the
differences arise from the PC12-B defect, and that it is most
severe in the case of the a7 gene product.
Tests for cyclophilin involvement
The possibility was considered that the PC12-B deficiency re-
sulted from an altered or lost cyclophilin, because a cyclophilin
has been shown to be necessary in Xenopus oocytes for expression
of functional AChRs from the a7 gene (Helekar et al., 1994).
This was not a strong likelihood in the present case, however,
because PC12-B cells show little deficit in expressing the a7/5-
HT3 chimeric receptors, whereas Xenopus oocytes are as depen-
dent on cyclophilin for 5-HT3 receptors as they are for receptors
composed of a7 subunits (Helekar et al., 1994).
A requirement for cyclophilin was tested in the present exper-
iments by exposing PC12-C cells for 24 hr to cyclosporin A, which
inhibits cyclophilin, and then assaying cell extracts to determine
whether the cells had reduced levels of AChRs. Cyclosporin A at
10 mM had no effect on the amounts of aBgt-binding AChRs with
a7 subunits, either as measured in cell extracts by RIA to assay
total receptors or as measured in cell culture with intact cells to
assay surface receptors selectively (Fig. 8). Similarly, cyclosporin
A at 10 mM had no effect on the number of AChRs binding
epibatidine in RIAs (127 6 4%, mean 6 SEM; n 5 3 experi-
ments) compared with untreated control cells. Higher concentra-
tions of cyclosporin A (30 mM) were toxic and caused substantial
cell loss. Blockade of new receptor expression by incubating cells
with 0.5 mg/ml tunicamycin (which blocks N-linked glycosylation
and prevents receptor maturation) showed that most of the aBgt-
binding receptors are lost during a 24 hr period (Fig. 8). The
tunicamycin-induced loss was apparent both in the total receptor
population and in those confined to the cell surface, indicating an
ongoing receptor turnover by the cells. If a cyclosporin
A-sensitive cyclophilin were required in PC12 cells, as it is in
Xenopus oocytes for assembly of AChRs composed of a7 sub-
units, then the cyclosporin A treatment of PC12-C cells should
have produced a large (90%) reduction in the amount of aBgt-
binding receptors tethered by anti-a7 mAbs in the RIA. It should
also have substantially reduced the number of aBgt-binding re-
ceptors on the cell surface, given the ongoing turnover. As a
result, it is unlikely that a lost or altered cyclophilin accounts for
the posttranslational deficiency in receptor production by PC12-B
cells.
DISCUSSION
This report provides the first demonstration, to our knowledge, of
ACh-evoked currents in PC12 cells that can be blocked by aBgt.
It resolves a long-standing puzzle in the field and shows that the
currents can vary dramatically among different PC12 populations.
The currents correlate well with the presence of aBgt-binding
AChRs on the cells, and the receptors contain a7 protein, but
there is no correlation between receptor levels and the amount of
a7 transcript in the cells. Instead, receptor expression is shown to
depend on a posttranslational event that is absent in some PC12
populations. The posttranslational event seems to be most critical
for expression of AChRs containing a7 subunits, although it may
influence less severely the expression of other ligand-gated ion
channels as well.
Like their counterparts on rat hippocampal neurons and chick
ciliary ganglion neurons (Zorumski et al., 1992; Alkondon and
Albuquerque, 1993; Alkondon et al., 1994; Zhang et al., 1994),
aBgt-sensitive AChRs on PC12 cells seem to activate and desen-
sitize rapidly. The quick desensitization of the receptors and their
variable numbers among PC12 cell populations may explain why
previous attempts failed to identify a current associated with the
receptors. Another contributing factor is likely to have been the
large aBgt-resistant ACh responses that may often obscure the
aBgt-sensitive component. No antagonists have yet been identi-
fied that selectively block the aBgt-resistant receptors.
The deficiency of PC12-B cells in producing functional aBgt-
binding AChRs cannot be ascribed to a defect in their a7 tran-
Figure 5. RT-PCR analysis comparing the coding regions of a7 mRNA
from PC12-B and -C cells. A, Schematic showing the a7 transcript nucle-
otide sequence (heavy line) with the start coinciding with the A of the
AUG start codon (Seguela et al., 1993). The expected PCR fragments
(thin lines) were a (982 bp), b (373 bp), c (907 bp), and d (386 bp). Primer
locations corresponded to nucleotide positions 18–38 (lightly stippled box),
627–646 (heavily stippled box), 981–1000 (open box), 1148–1167 (solid
box), and 1516–1534 (hatched box). The sequence encoded by the RNase
protection probe is indicated by the hatched bar. B, Agarose gels showing
the amplified PCR fragments. First-strand cDNA was synthesized using
reverse transcriptase and total RNA isolated from PC12-B and -C cells as
templates. PCR was performed with the indicated sets of primers. Ali-
quots of the PCR reactions were run on 1.1% agarose gels, which were
stained with ethidium bromide and photographed using a Polaroid cam-
era. Lanes 1 and 10, M, Molecular weight standards (100 bp ladder from
Gibco-BRL); lanes 2 and 3, PCR fragment a; lanes 4 and 5, fragment b;
lanes 6 and 7, fragment c; lanes 8 and 9, fragment d. B, PC12-B RNA as
template; C, PC12-C RNA as template. No differences were detected in
the fragments amplified from the PC12-B and -C RNA, and in each case
the fragment had the full size expected. Similar results were obtained
when PCR was performed on cDNA synthesized from two independent
RNA preparations.
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scripts and, therefore, differs from that found previously in a
PC12 variant (Fanger et al., 1995). PC12-B cells have more a7
mRNA than do PC12-C cells, which make the receptors, and the
transcripts are indistinguishable by Northern blot analysis, RNase
protections, and RT-PCR analysis over the regions examined.
Moreover, a7 protein is present in PC12-B cells and has the same
size and antigenicity with respect to mAbs 319 and A7–1 as does
a7 protein in PC12-C. The PC12-B transcript, therefore, seems
competent to generate full-length in-frame a7 protein. The re-
sults indicate that a posttranscriptional deficiency is most likely to
account for the limitations of PC12-B cells in producing func-
tional AChRs with a7 subunits.
Heterologous expression of the a7 gene alone in either Xeno-
pus oocytes or stably transfected cell lines is sufficient to generate
functional AChRs that are blocked by aBgt (Couturier et al.,
1990; Seguela et al., 1993; Puchacz et al., 1994; Gopalakrishnan et
al., 1995; Quik et al., 1996). The inability of PC12-B cells to do so
despite their having what seems to be competent a7 mRNA,
therefore, implies a posttranslational block. Strong evidence of
such a block was provided by the transfection experiments show-
ing that PC12-B cells are two orders of magnitude less efficient at
producing aBgt-binding AChRs from an a7 gene construct than
are PC12-C cells. Differences of only a few-fold were observed
between PC12-B and -C cells when comparing their abilities to
make receptors containing the a4 and b2 subunits or chimeric
a7/5-HT3 receptor subunits from transfected gene constructs.
These small differences may reflect differences in the efficiency of
transfection between PC12-B and -C cells. Alternatively, the
posttranslational defect restricting receptor production in PC12-B
cells applies to many kinds of ligand-gated ion channels but is
most stringent for receptors containing a7 protein.
What is the nature of the posttranslational block? It cannot be
ascribed to differences in growth medium and is not overcome by
NGF. One possibility is that the block is confined to AChRs
containing a7 subunits and reflects a requirement for other kinds
of subunits to be co-assembled in the receptors. Failure of a7
subunits to bind appropriate partners for co-assembly could result
in rapid turnover of the protein and account for the low levels
present in PC12-B cells. Although heterologous expression of the
a7 subunit alone can produce functional aBgt-sensitive AChRs,
as cited above, it is difficult to exclude the possibility that the
usually limited amounts of functional receptor obtained in such
cases are made possible by small amounts of other required
AChR gene products being expressed at low levels by the host
cell. Immunological analysis of native AChRs containing a7
subunits in chick ciliary ganglion neurons, for example, has indi-
cated that the receptors lack all of the known AChR gene
products expressed by chick neurons (Vernallis et al., 1993), but
it remains possible that other AChR genes remain to be
identified.
A different possibility is that the posttranslational block reflects
loss of a specific component(s) required for efficient assembly or
stabilization of certain classes of ligand-gated ion channels. The
defect in PC12-B cells is not global in its effects, because the cells
can express other kinds of receptors from both transfected and
endogenous genes. The latter include AChRs capable of binding
epibatidine and generating aBgt-resistant ACh responses. The
fact that PC12-B cells, however, generally have higher levels of all
AChR transcripts tested (with the exception of b4) and yet lower
levels of epibatidine binding than do PC12-C cells suggests that
the PC12-B defect may extend in a mild form to other kinds of
ligand-gated ion channels. The post-translational defect described
here is different from that preventing expression of NMDA
receptors in PC12 cells. Although the cells synthesize NMDAR1
mRNA, they do not produce functional NMDA receptors and
have little NMDAR1 protein until transfected with an NMDAR1
cDNA construct (Sucher et al., 1993). The simplest interpretation
is that the endogenous NMDAR1 transcripts do not permit
significant translation, perhaps because of interference from their
untranslated regions (Sucher et al., 1993).
Precedent for different requirements in receptor assembly
comes from studies on heterologous expression of AChR genes in
Xenopus oocytes. Production of functional homomeric, but not
heteromeric, AChRs containing a7 protein is blocked by cyclo-
sporin A through its inhibition of cyclophilin (Helekar et al.,
1994). A lost or defective cyclophilin is unlikely to account for the
deficiency detected here in PC12-B cells, because cyclosporin A
treatment did not prevent receptor production in PC12-C cells. In
addition, PC12-B cells are nearly as efficient as PC12-C cells in
expressing an a7/5-HT3 chimeric receptor, whereas expression of
5-HT3 receptors in Xenopus oocytes mimics that of receptors
containing a7 subunits in requiring a cyclophilin (Helekar et al.,
1994).
The inability of PC12-A cells to produce aBgt-insensitive ACh
responses deserves comment. Some epibatidine binding was de-
tected in the cell extracts indicating the existence of AChRs.
Possibly the receptors were sequestered in an intracellular pool
and therefore unable to generate responses. The low levels of b4
Figure 6. Immunoblot analysis showing a7 protein in PC12 AChRs. A,
AChRs that bind aBgt were affinity-purified from PC12-B and -C cell
extracts by adsorption to aBgt coupled to Actigel beads. The adsorbed
material was eluted and analyzed by immunoblots probed with the anti-a7
mAb A7–1 and visualized using a horseradish peroxidase-coupled sec-
ondary antibody followed by enhanced chemiluminescence. A single
species of about 60 kDa was obtained from PC12-C samples (lane 1).
Nicotine at 250 mM (lane 2) blocked adsorption of the component to the
aBgt-Actigel, indicating the specificity of the affinity purification. No
components were obtained specifically when PC12-B cell extracts were
analyzed by similar methods (lanes 3 and 4 ). Molecular weight standards
(Bio-Rad) are as follows: phosphorylase B, 97 kDa; serum albumin, 66
kDa; ovalbumin, 45 kDa; and carbonic anhydrase, 31 kDa. Similar results
were obtained in a second experiment using mAb A7–1 as probe and in
two experiments using mAb 319 as probe. B, Total a7 protein from
PC12-B and -C cell extracts was analyzed by immunoprecipitating protein
with the a7-specific mAb 319 coupled to Actigel and probing immunob-
lots of the purified material with mAb A7–1. A species of 60 kDa
component was obtained from both PC12-C (lane 1) and PC12-B (lane 2)
cell extracts, although the latter contained much less of the component.
Similar results were obtained in a second experiment. The band was
absent when rat IgG-Actigel was substituted for the mAb 319-Actigel as a
negative control (data not shown).
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transcript in PC12-A cells may have limited the ability of the cells
to produce receptors targeted for the cell surface. It remains
unclear, however, why the a3 and b2 gene products expressed by
the cells were not alone sufficient to generate functional aBgt-
resistant AChRs as they do in Xenopus oocytes (Boulter et al.,
1987; Deneris et al., 1988; Gross et al., 1991).
PC12 cells passaged many times in culture under different
conditions might well generate diverse variants. What is interest-
ing about the present variations is the possibility that they reflect
differences in the machinery cells use to assemble and maintain
certain classes of membrane proteins. Ligand-gated ion channels
are multimeric proteins containing both hydrophobic and hydro-
philic transmembrane domains constituting the channel. They
pose considerable challenges from a structural biological point of
view in terms of proper assembly and insertion into the cell
membrane. Neurons must efficiently produce large numbers of
such channel proteins while avoiding potentially lethal errors such
as creating spontaneously active channels or ones that permit
excessive calcium to enter the cell. A gain-of-function mutation in
a Caenorhabditis elegans gene homologous to a7 illustrates the
potential danger of producing inappropriate receptors; the muta-
tion causes cell death (Treinin and Chalfie, 1995). Quality control
may come in the form of special chaperones that guide the
assembly process and help prevent or discard errors.
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